4/24
07:07 pm
vtrs
Inflation Reduction Act: A Bullish Catalyst For Viatris Inc. [Seeking Alpha]
Low
Report
Inflation Reduction Act: A Bullish Catalyst For Viatris Inc. [Seeking Alpha]
4/22
04:14 am
vtrs
Global Epilepsy Treatment Drugs Market Size To Exceed USD 12.1 Billion By 2033 | CAGR Of 4.36% [Yahoo! Finance]
Low
Report
Global Epilepsy Treatment Drugs Market Size To Exceed USD 12.1 Billion By 2033 | CAGR Of 4.36% [Yahoo! Finance]
4/19
12:49 pm
vtrs
Viatris Announces Product Donations To Direct Relief of More Than 7 Million Doses of Medicine To Support Access to Medicine and Healthcare [Yahoo! Finance]
Low
Report
Viatris Announces Product Donations To Direct Relief of More Than 7 Million Doses of Medicine To Support Access to Medicine and Healthcare [Yahoo! Finance]
4/16
04:30 pm
vtrs
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
Low
Report
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
4/15
08:13 am
vtrs
Viatris Appoints Corinne Le Goff as Chief Commercial Officer [Yahoo! Finance]
Low
Report
Viatris Appoints Corinne Le Goff as Chief Commercial Officer [Yahoo! Finance]
4/15
08:00 am
vtrs
Viatris Appoints Corinne Le Goff as Chief Commercial Officer
Low
Report
Viatris Appoints Corinne Le Goff as Chief Commercial Officer
4/15
07:10 am
vtrs
Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada [Yahoo! Finance]
Low
Report
Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada [Yahoo! Finance]
4/8
05:03 pm
vtrs
Viatris Stock: Way Too Undervalued With $1 Billion Buyback Potential [Seeking Alpha]
Low
Report
Viatris Stock: Way Too Undervalued With $1 Billion Buyback Potential [Seeking Alpha]
4/5
01:48 pm
vtrs
UK's Theramex sees no impact to HRT products supply after CMA probe [Reuters]
Low
Report
UK's Theramex sees no impact to HRT products supply after CMA probe [Reuters]
4/5
01:46 pm
vtrs
UK's Theramex sees no impact to HRT products supply after CMA probe [Yahoo! Finance]
Low
Report
UK's Theramex sees no impact to HRT products supply after CMA probe [Yahoo! Finance]
4/4
09:00 am
vtrs
Viatris- Theramex deal for women's care products raises antitrust concerns in U.K. Apr. 04, 2024 8:55 AM ET By: Dulan Lokuwithana , SA News Editor [Seeking Alpha]
Low
Report
Viatris- Theramex deal for women's care products raises antitrust concerns in U.K. Apr. 04, 2024 8:55 AM ET By: Dulan Lokuwithana , SA News Editor [Seeking Alpha]
4/4
06:58 am
vtrs
UPDATE 1-UK watchdog says Theramex-Viatris deal raises competition concerns [Yahoo! Finance]
Low
Report
UPDATE 1-UK watchdog says Theramex-Viatris deal raises competition concerns [Yahoo! Finance]
4/4
06:28 am
vtrs
UK watchdog says Theramex-Viatris deal raises competition concerns [Reuters]
Low
Report
UK watchdog says Theramex-Viatris deal raises competition concerns [Reuters]
4/3
11:25 am
vtrs
Global Naloxone Market to Reach $2.1 Billion by 2030 with a CAGR of 10.8% - Market Growth Driven by Increasing Drug Dependency and Public Awareness [Yahoo! Finance]
Low
Report
Global Naloxone Market to Reach $2.1 Billion by 2030 with a CAGR of 10.8% - Market Growth Driven by Increasing Drug Dependency and Public Awareness [Yahoo! Finance]
4/2
10:09 pm
vtrs
Contraceptive Market Projected to Reach $119.89 billion by 2030 - Exclusive Report by 360iResearch [Yahoo! Finance]
Low
Report
Contraceptive Market Projected to Reach $119.89 billion by 2030 - Exclusive Report by 360iResearch [Yahoo! Finance]
4/2
09:35 am
vtrs
Global Catecholamine Market Poised for Explosive Growth US$ 9.3 Billion by 2034, Driven by Rising Demand in Neurological and Adrenal Treatments | Future Market Insights [Yahoo! Finance]
Low
Report
Global Catecholamine Market Poised for Explosive Growth US$ 9.3 Billion by 2034, Driven by Rising Demand in Neurological and Adrenal Treatments | Future Market Insights [Yahoo! Finance]
4/1
12:27 pm
vtrs
Teva and Viatris revives chance to dispute J&J's schizophrenia drug patent [Seeking Alpha]
Low
Report
Teva and Viatris revives chance to dispute J&J's schizophrenia drug patent [Seeking Alpha]
4/1
11:56 am
vtrs
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent [Reuters]
Low
Report
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent [Reuters]
4/1
07:29 am
vtrs
Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris [Yahoo! Finance]
Low
Report
Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris [Yahoo! Finance]
4/1
07:06 am
vtrs
Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States [Yahoo! Finance]
Low
Report
Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States [Yahoo! Finance]
4/1
06:59 am
vtrs
Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States
Low
Report
Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States
3/30
02:14 am
vtrs
Viatris Stock Is Still Worth Buying [Seeking Alpha]
Low
Report
Viatris Stock Is Still Worth Buying [Seeking Alpha]
3/29
12:57 pm
vtrs
Why Is Viatris (VTRS) Down 3.5% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is Viatris (VTRS) Down 3.5% Since Last Earnings Report? [Yahoo! Finance]
3/29
07:09 am
vtrs
Global Pregabalin Market Size To Worth USD 2.18 Billion By 2033 | CAGR of 2.82% [Yahoo! Finance]
Low
Report
Global Pregabalin Market Size To Worth USD 2.18 Billion By 2033 | CAGR of 2.82% [Yahoo! Finance]
3/27
07:15 am
vtrs
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline [Yahoo! Finance]
Low
Report
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline [Yahoo! Finance]